Technology and Competitive Environment of Enzyme in China

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits

Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Huifeng BioPharmaceutical Technology Inc. SWOT Analysis report provides ...

Industries: Biopharmaceutical | Countries: China

Sanjiu Yigong Biopharmaceutical & Chem (000403) - Financial and Strategic SWOT Analysis Review

Sanjiu Yigong Biopharmaceutical & Chem (000403) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Sanjiu Yigong Biopharmaceutical & Chemical Inc. (Sanjiu Yigong) is engaged in the development, manufacture and sale of pharmaceutical products. In adddition, the company also generates and distributes electricity. Its product portfolio comprises of biopharmaceutical blood products. The company ...

Industries: Biopharmaceutical | Countries: China

Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits

Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sino Biopharmaceutical Limited SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: China

China Recombinant Protein Drug Industry Report, 2014-2017

China Recombinant Protein Drug Industry Report, 2014-2017

  • $ 2 500
  • Industry report
  • by Research In China
  • November 2014
  • 127 pages

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will ...

Industries: Biopharmaceutical | Countries: China

Bio Products Markets in China

Bio Products Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • November 2014
  • 349 pages

China's demand for Bio Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption ...

Industries: Biopharmaceutical | Countries: China

Global and China Monoclonal Antibody Industry Report, 2014-2019

Global and China Monoclonal Antibody Industry Report, 2014-2019

  • $ 2 600
  • Industry report
  • by Research In China
  • October 2014
  • 136 pages

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biotech drugs with the fastest CAGR in recent years. Global blockbuster monoclonal antibody agents are still ...

Industries: Biopharmaceutical | Countries: China

Pea Protein Market by Type [Isolates, Concentrates, and Textured], Application (Meat Extenders & Analogs, Snacks & Bakery Products, Nutritional Supplements, Beverages, and Others), & Geography - Global Trends & Forecasts to 2019

Pea Protein Market by Type [Isolates, Concentrates, and Textured], Application (Meat Extenders & Analogs, Snacks & Bakery Products, Nutritional Supplements, Beverages, and Others), & Geography - Global Trends & Forecasts to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • September 2014
  • 153 pages

The pea protein market size is projected to increase due to the rising vegetarian population. Pea protein contains a high nutrional profile and functionality. The emerging markets with increasing demand for pea protein are estimated to generate potential opportunities in the market. The pea protein market ...

Industries: Biopharmaceutical | Countries: World, North America, Europe, China, Japan, Australia, Netherlands, United States, Brazil, Mexico, Canada, Spain, Italy, France, Germany, Belgium

Meidu Holding Co., Ltd (600175) - Company Capsule

Meidu Holding Co., Ltd (600175) - Company Capsule

  • $ 75
  • Company report
  • by World Market Intelligence Ltd
  • September 2014
  • 26 pages

Synopsis World Market Intelligence's "Meidu Holding Co., Ltd (600175) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, key employees. Summary ...

Industries: Biopharmaceutical | Countries: China

Response Biomedical Corporation (Symbol:RBM) SWOT Analysis, Strategy, Revenues and Profits

Response Biomedical Corporation (Symbol:RBM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • August 2014
  • 43 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Response Biomedical Corporation SWOT Analysis report provides you ...

Industries: Biopharmaceutical | Countries: China

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Sino Biopharmaceutical Limited (1177)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Sino Biopharmaceutical Limited (1177)

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 32 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sino Biopharmaceutical Limited (1177) SWOT Analysis report provides ...

Industries: Biopharmaceutical | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.